Note - The COVID-19 Vaccine Group is based on the interim recommendations from ACIP. As additional guidelines are published, the COVID-19 logic in ICE will be updated. This release includes support for the following COVID-19 vaccines:
- Pfizer COVID-19 vaccine (CVX 208)
- Moderna COVID-19 vaccine (CVX 207)
- Janssen COVID-19 vaccine (CVX 212)
- COVID-19, Unspecified Formulation (CVX 213)
Two Shot Same Day Exception Rules for COVID-19
The Duplicate Shot, Same Day rules do not apply for COVID-19 Vaccine Group, due to the fact that the absolute minimum intervals between dose 1 and dose 2 = 0 days in both the Pfizer COVID-19 2-dose Series and Moderna COVID-19 2-dose Series.
Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
COVID-19 Vaccine Group Evaluation and Forecasting Rules
General Rules for COVID-19
General rules are not series-specific; general rules apply to the entire vaccine group.
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Rules for Recommending at the CVX Code vs. Vaccine Group Level
|
COVID-19 Vaccines
...
CVX Code
...
Name
...
Moderna COVID-19 Vaccine
...
208
...
Pfizer COVID-19 Vaccine
...
(*) If a COVID-19 vaccine is administered before the vaccine's minimum age or series' recommended age (16y - 4d for Pfizer; 18y - 4d for Moderna), or below the series' minimum interval, supplemental text is returned to alert the user of this fact even though the may have been evaluated as Valid. See "Series Special Rules" for all series below for more details. (Note: the running distribution must have the output_supplemental_text option enabled for the supplemental text to be returned.)
Combination Vaccines that Include COVID-19
No combination vaccines exist, at this time, that include COVID-19 and count toward completion of the Pfizer COVID-19 2-dose series.
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
CVX Code Specific RulesCVX Code Absolute Minimum Age
Rule for CVX 213
|
Immunization Series and Selection Rules
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Name
Series Selection RulesThere are three series for this vaccine group: the Pfizer COVID-19 2-dose series, Moderna COVID-19 2-dose series, and Janssen COVID-19 1-dose series. The rules for determining which series applies are:
|
Immunization Series: Pfizer COVID-19 2-dose Series
The Pfizer COVID-19 2dose series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
...
Dose
...
Series Name
...
Absolute Minimum
Age
...
Routine
Age
...
1
...
Pfizer COVID-19 2-dose Series
...
0 days
...
2
...
Pfizer COVID-19 2-dose Series
...
0 days
...
16 years
...
Vaccine Dose Parameters - Minimum and Recommended Intervals
...
Doses
...
Series Name
...
Absolute Minimum Interval
...
Minimum Recommended Interval
...
Dose 1 to 2
...
Pfizer COVID-19 2-dose Series
...
0 days
...
21 days
...
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Rule for CVX 212 (Janssen COVID-19 Vaccine)
|
Immunization Series: Moderna COVID-19 2-dose series
The Moderna COVID-19 2-dose series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
...
Dose
...
Series Name
...
Absolute Minimum
Age
...
Routine
Age
...
Latest Recommended Age (less than)
...
1
...
Moderna COVID-19 2-dose Series
...
0 days
...
18 years
...
N/A
...
2
...
Moderna COVID-19 2-dose Series
...
N/A
Vaccine Dose Parameters - Minimum and Recommended Intervals
...
Doses
...
Series Name
...
Absolute Minimum Interval
...
Recommended Interval
...
Dose 1 to 2
...
Moderna COVID-19 2-dose Series
...
0 days
...
28 days
...
borderColor | #CCFFFF |
---|---|
bgColor | #CCFFFF |
titleBGColor | #99FFFF |
borderStyle | solid |
Series Special Rules
...
This page specifies the COVID-19 logic implemented by ICE for recommendations before September 12, 2023.
For COVID-19 logic for recommendations as of September 12, 2023 onwards, see COVID-19 Vaccine Group - September 2023 Onwards.
Two Shot Same Day Exception Rules for COVID-19
For COVID-19 shots administered:
- before 10/25/2021, the Duplicate Shot, Same Day rules do NOT apply because absolute minimum intervals between dose 1 and dose 2 = 0 days (before 10/25/2021) in both the Pfizer COVID-19 2-dose series and Moderna COVID-19 2-dose series.
- on or after 10/25/2021, the Duplicate Shot, Same Day rules apply because absolute minimum intervals between dose 1 and dose 2 > 0 days (on or after 10/25/2021) in both the Pfizer COVID-19 2-dose series and Moderna COVID-19 2-dose series.
Panel | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
|
COVID-19 Vaccine Group Evaluation and Forecasting Rules
General Rules for COVID-19
General rules are not series-specific; general rules apply to the entire vaccine group.
Panel | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||
Anchor |
|
Anchor | ||||
---|---|---|---|---|
|
- Once a patient completes:
- the Pfizer COVID-19 Series,
- and is < 5 years old:
- if the execution date is < 3/17/2023, the recommendation is Not Recommended and the reason code is COMPLETE.
- if the execution date is >= 3/17/2023 and a bivalent vaccine (CVX 229, CVX 230, CVX 300, CVX 301, CVX 302, CVX 519, or CVX 520) has not been administered, recommend a dose of COVID-19 at the vaccine group level and recommended interval (8 weeks) or on 3/17/2023, whichever date is latest, along with recommendation reasons ADMINISTER_COVID19_BIVALENT_VACCINE and SUPPLEMENTAL_TEXT and Descriptive Text: "Patients who previously completed a 3-dose monovalent primary series are recommended to receive 1 bivalent booster dose, at least 8 weeks after completion of the monovalent primary series.
- and is >= 5 years old:
- if the execution date is >= 4/19/2023:
- See Section "Rules for Booster Dose", Bullet Point: "After completion of the Pfizer COVID-19 Series, the execution date is >= 3/17/2023, and the patient is < 5 years of age"
- if the execution date is >= 4/19/2023:
- if the execution date is < 9/2/2022:
- and is >= 5 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (5 months) or at recommended age (5 years), whichever date is later, along with recommendation reason code BOOSTER_DOSE.
if the execution date is >= 9/2/2022 and is < 4/19/2023:
and is >= 5 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks) or at recommended age (5 years), whichever date is later, along with recommendation reason code BOOSTER_DOSE.
See “Rules for Booster Dose” for booster dose recommendations for the Pfizer COVID-19 Series.
- and is < 5 years old:
- the Mixed Product or Moderna COVID-19 Series,
- if the execution date is >= 4/19/2023:
- See Section "Rules for Booster Dose", Bullet Point: "After completion of the Pfizer COVID-19 Series, Mixed Product COVID-19 Series, Moderna COVID-19 Series, Janssen COVID-19 Series or Novavax COVID-19 Series, and the execution date is >= 4/19/2023"
- if the execution date is >= 12/9/2022 and < 4/19/2023:
- and is >= 6 months of age, recommend a booster dose of COVID-19 at recommended interval (8 weeks), recommended age (6 months) or on 12/9/2022, whichever date is latest, along with recommendation reason code BOOSTER_DOSE.
- if the execution date is >= 10/12/2022 and < 12/9/2022:
- and is >= 5 years and < 12 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks), recommended age (5 years) or on 10/12/2022, whichever date is latest, along with recommendation reason code BOOSTER_DOSE.
- if the execution date is >= 9/2/2022:
- and is < 12 years old, the recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK.
- and is >= 12 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks), recommended age (12 years) or on 9/2/2022, whichever date is latest, along with recommendation reason code BOOSTER_DOSE.
See “Rules for Booster Dose” for booster dose recommendations for the Moderna COVID-19 Series.
- if the execution date is >= 4/19/2023:
- the Janssen COVID-19 Series,
- If the execution date is >= 4/19/2023:
- See Section "Rules for Booster Dose", Bullet Point: "After completion of the Pfizer COVID-19 Series, Mixed Product COVID-19 Series, Moderna COVID-19 Series, Janssen COVID-19 Series or Novavax COVID-19 Series, and the execution date is >= 4/19/2023"
- Otherwise:
- and is >= 12 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks), along with recommendation reason code BOOSTER_DOSE.
- and is < 12 years old, the recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK.
See “Rules for Booster Dose” for booster dose recommendations for the Janssen COVID-19 Series.
- If the execution date is >= 4/19/2023:
- the Novavax COVID-19 Series,
- If the execution date is >= 4/19/2023:
- See Section "Rules for Booster Dose", Bullet Point: "After completion of the Pfizer COVID-19 Series, Mixed Product COVID-19 Series, Moderna COVID-19 Series, Janssen COVID-19 Series or Novavax COVID-19 Series, and the execution date is >= 4/19/2023"
- Otherwise:
- and is < 12 years old, the recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK.
- and is >= 12 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks) or at recommended age (12 years), whichever date is later, along with recommendation reason code BOOSTER_DOSE.
- If the execution date is >= 4/19/2023:
a COVID-19 vaccine series not authorized by the FDA, but authorized by the WHO, or a COVID-19 vaccine series not authorized by the FDA or WHO, but is an active COVID-19 vaccine candidate as part of a U.S.-based clinical trial of a COVID-19 vaccine,
- if the execution date is < 9/2/2022:
recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (5 months) or at recommended age (12 years), whichever date is later, along with recommendation reason code BOOSTER_DOSE.
if the execution date is >= 10/12/2022:
and is >= 5 years and < 12 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks), recommended age (5 years) or on 10/12/2022, whichever date is latest, along with recommendation reason code BOOSTER_DOSE.
if the execution date is >= 9/2/2022:
and is < 12 years old, the recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK.
and is >= 12 years old, recommend a booster dose of COVID-19 (at vaccine group level) at recommended interval (8 weeks), recommended age (12 years), or on 9/2/2022, whichever date is latest, along with recommendation reason code BOOSTER_DOSE.
See “Rules for Booster Dose” for booster dose recommendations for the these series.
- if the execution date is < 9/2/2022:
- the Pfizer COVID-19 Series,
Rules for an Additional Dose1
- If a patient completes a COVID-19 vaccine series via the Moderna COVID-19 Series or COVID-19 vaccine series not authorized by the FDA, but authorized by the WHO, or a COVID-19 vaccine series not authorized by the FDA or WHO, but is an active COVID-19 vaccine candidate as part of a U.S.-based clinical trial of a COVID-19 vaccine and receives an additional shot of CVX 207, CVX 208, CVX 211, CVX 212, CVX 213, CVX 217, CVX 218, CVX 219, CVX 221, CVX 227, CVX 228, CVX 229, CVX 300, CVX 301, CVX 302, CVX 519, CVX 520:
- if the execution date is < 9/2/2022:
- at < 5 months after series completion, then evaluate the shot as Valid / SUPPLEMENTAL_TEXT; Descriptive Text: "The timing of the administration of this shot does not follow the guidelines regarding the minimum interval of
- if the execution date is < 9/2/2022:
Rule for CVX 212 (Janssen COVID-19 Vaccine)
- If CVX 212 (Janssen COVID-19 Vaccine) is reported for Target Dose 2, the Janssen COVID-19 1-dose Series applies and the series is complete. Therefore,
- evaluate Target Dose 2 (CVX 212) as Valid.
- evaluate Target Dose 1 as Accepted and the reason code is VACCINE_NOT_COUNTED_BASED_ON_MOST_RECENT_VACCINE_GIVEN.
Immunization Series: Janssen COVID-19 1-dose Series
...
Rules for Booster Dose2Any of the FDA-Approved COVID-19 vaccines (except CVX 218) can be used for booster vaccination, regardless of the vaccine product used for primary vaccination. When a heterologous or “mix and match” booster dose is administered, the eligible population and dosing intervals are those of the vaccine used for primary vaccination. Recommendation Rules for Booster Dose or Requirement for a Dose with a Bivalent Vaccine
Evaluation Rules for Booster Dose
Rules for Evaluation of Extra Shots After Additional Dose1 and/or Booster Doses and/or Needed Bivalent Dose2
|
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
COVID-19 Vaccines
CVX Code | Name | Absolute Minimum Age | Absolute Maximum Age | Counts towards U.S. Vaccination |
---|---|---|---|---|
207 | Moderna COVID-19 Vaccine | 0 days | Yes | |
208 | Pfizer COVID-19 Vaccine | 0 days | Yes | |
210 | AstraZeneca COVID-19 Vaccine | 0 days | Yes | |
211 | Novavax COVID-19 Vaccine | 0 days | Yes | |
212 | Janssen COVID-19 Vaccine | 0 days | Yes | |
213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | 0 days | Yes | |
217 | Pfizer COVID-19 Vaccine (>= 12 years) | 0 days | Yes | |
218 | Pfizer COVID-19 Vaccine | 0 days | 18 years - 1 day | Yes |
219 | Pfizer COVID-19 Vaccine | 0 days | 6 years - 1 day | Yes |
221 | Moderna COVID-19 Vaccine | 0 days | Yes | |
227 | Moderna COVID-19 Vaccine (Inactive) | 0 days | 13 years - 1 day | Yes |
228 | Moderna COVID-19 Vaccine | 0 days | 7 years - 1 day | Yes |
229 | Moderna COVID-19 Vaccine, Bivalent | 0 days | Yes | |
230 | Moderna, COVID-19 Vaccine, Bivalent Booster | 0 days | 7 years - 1 day | Yes |
300 | Pfizer COVID-19 Vaccine, Bivalent | 0 days | Yes | |
301 | Pfizer COVID-19 Vaccine, Bivalent | 0 days | 12 years - 1 day | Yes |
302 | Pfizer, COVID-19 Vaccine, Bivalent | 0 days | 6 years - 1 day | |
500 | COVID-19 Non-US Vaccine, Product Unknown | No | ||
501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | No | ||
502 | COVID-19 IV Non-US Vaccine (COVAXIN) | 0 days | Yes | |
503 | COVID-19 LAV Non-US Vaccine (COVIVAC) | No | ||
504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | No | ||
505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) | No | ||
506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) | No | ||
507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbology Chinese academy of Sciences) | No | ||
508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | No | ||
509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) | No | ||
510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | 0 days | Yes | |
511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | 0 days | Yes | |
512 | COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | 18 years - 4 days | Yes | |
513 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | No | ||
514 | COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | No | ||
515 | COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | No | ||
516 | COVID-19 Inactivated Non-US Vaccine (Minhai Biotechnology Co, KCONVAC) | No | ||
517 | COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | No | ||
518 | COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) | No | ||
519 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna | 0 days | Yes | |
520 | COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech | 0 days | Yes | |
521 | COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK | No |
Combination Vaccines that Include COVID-19
No combination vaccines exist, at this time, that include COVID-19 and count toward completion of the Pfizer COVID-19 2-dose series.
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
CVX Code Specific RulesCVX Code Absolute Minimum Age
CVX Code Absolute Maximum Age
Rule for CVX 218, CVX 219, CVX 227, CVX 228, CVX 229, CVX 230, CVX 301, CVX 302
Rule for Bivalent Vaccines (CVX 229, CVX 230, CVX 300, CVX 301, CVX 301, CVX 519, CVX 520)
Rule for CVX 213
Rules for COVID-19 Vaccines Not Authorized by FDA2The following set of rules apply to 1) COVID-19 Vaccines Not Authorized by FDA, but Authorized by WHO and, 2) COVID-19 Vaccines Not Authorized by FDA or WHO, but is an Active COVID-19 Vaccine Candidate as part of a U.S.-based Clinical Trial of a COVID-19 Vaccine.
|
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Notes
|
Immunization Series and Selection Rules
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Name
Series Selection RulesThere are five series for this vaccine group: Pfizer COVID-19 Series, Moderna COVID-19 Series, Mixed Product COVID-19 Series, Janssen COVID-19 Series, and Novavax COVID-19 Series. The rules for determining which series applies are:
|
Immunization Series: Pfizer COVID-19 Series
The Pfizer COVID-19 Series is complete after 2 or 3 doses, depending on age (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum Age | Minimum Age | Routine Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
2 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
3 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219, 300, 301, 302 | 229, 230 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Pfizer COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise, 17 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 21 days |
N/A |
Dose 2 to 3 | Pfizer COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
Immunization Series: Moderna COVID-19 Series
The Moderna COVID-19 series is complete after 2 doses(not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228, 229 | N/A |
2 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228, 229 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Moderna COVID-19 | 0 days if dose 2 administered < 10/25/2021 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 6 years of age Otherwise, 24 days if dose 2 administered >= 10/25/2021 | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 6 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 administered >= 6 years of age Otherwise, 28 days | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Vaccine to Recommend
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
Immunization Series: Mixed Product COVID-19 Series
The Mixed Product COVID-19 Series is complete after 2 or 3 doses, depending on age(not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
2 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
3 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 211, 213, 217, 218, 219, 221, 227, 228, 300, 301, 302 | 229, 230 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Mixed Product COVID-19 Series | 8 weeks - 4 days if dose 2 administered >= 4/19/2023 and dose 1 administered >= 5 years of age Otherwise:
| 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | 8 weeks if the execution date is >= 4/19/2023 and dose 1 was administered >= 5 years of age Otherwise, 28 days | N/A |
Dose 2 to 3 | Mixed Product COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 211 (Novavax COVID-19 vaccine)
Rule for CVX 212 (Janssen COVID-19 vaccine)
|
Immunization Series: Janssen COVID-19 Series
The Janssen COVID-19 Series is complete after 1 dose.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Janssen COVID-19 Series | 0 days | 18 years | 18 years | N/A | 212 | N/A |
Panel | ||||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
Series Special Rules
|
Immunization Series: Novavax COVID-19 Series
The Novavax COVID-19 Series is complete after 2 doses (not including booster dose(s)).
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 |
Novavax COVID-19 |
Series |
12 years - 4 days |
12 years |
12 years | N/A |
211 | |||||
2 | Novavax COVID-19 Series | 12 years - 4 days | 12 years | 12 years | N/A |
...
borderColor | #CCFFFF |
---|---|
bgColor | #CCFFFF |
titleBGColor | #99FFFF |
borderStyle | solid |
Series Special Rules
...
211 |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Novavax COVID-19 Series | 17 days | 21 days | 21 days | 8 weeks |